Free Trial

Crossmark Global Holdings Inc. Has $22.38 Million Stake in Procter & Gamble Company (The) (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Crossmark Global Holdings Inc. decreased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 1.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 131,329 shares of the company's stock after selling 2,019 shares during the quarter. Crossmark Global Holdings Inc.'s holdings in Procter & Gamble were worth $22,381,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Navigoe LLC bought a new position in Procter & Gamble during the 4th quarter worth approximately $31,000. Capital A Wealth Management LLC bought a new position in Procter & Gamble during the 4th quarter worth approximately $31,000. Hoey Investments Inc. boosted its stake in Procter & Gamble by 321.7% during the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock worth $33,000 after acquiring an additional 148 shares during the last quarter. LFA Lugano Financial Advisors SA bought a new position in Procter & Gamble during the 4th quarter worth approximately $34,000. Finally, 10Elms LLP bought a new position in Procter & Gamble during the 4th quarter worth approximately $34,000. Institutional investors and hedge funds own 65.77% of the company's stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Piper Sandler lifted their price objective on shares of Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a research note on Monday, May 5th. Barclays reaffirmed an "equal weight" rating on shares of Procter & Gamble in a research note on Thursday, March 27th. Citigroup cut their price target on shares of Procter & Gamble from $200.00 to $181.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Raymond James Financial cut their price target on shares of Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating on the stock in a research note on Friday, April 25th. Finally, Redburn Partners set a $161.00 price target on shares of Procter & Gamble in a research note on Thursday, May 1st. Eight analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Procter & Gamble has a consensus rating of "Moderate Buy" and a consensus price target of $178.45.

Read Our Latest Report on Procter & Gamble

Insider Transactions at Procter & Gamble

In other news, insider Moses Victor Javier Aguilar sold 10,520 shares of the stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $158.67, for a total value of $1,669,208.40. Following the sale, the insider directly owned 25,182 shares of the company's stock, valued at approximately $3,995,627.94. This represents a 29.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Jennifer L. Davis sold 1,000 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the sale, the chief executive officer directly owned 51,965 shares of the company's stock, valued at approximately $8,386,111.70. This represents a 1.89% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.18% of the company's stock.

Procter & Gamble Stock Performance

NYSE PG opened at $160.72 on Monday. The company has a current ratio of 0.71, a quick ratio of 0.50 and a debt-to-equity ratio of 0.47. The firm's fifty day moving average price is $162.10 and its two-hundred day moving average price is $165.25. Procter & Gamble Company has a 1 year low of $156.58 and a 1 year high of $180.43. The firm has a market capitalization of $376.82 billion, a P/E ratio of 25.51, a price-to-earnings-growth ratio of 4.58 and a beta of 0.40.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, topping the consensus estimate of $1.53 by $0.01. Procter & Gamble had a net margin of 18.46% and a return on equity of 32.67%. The business had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. During the same period last year, the company earned $1.52 EPS. The firm's revenue was down 2.1% compared to the same quarter last year. As a group, research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Monday, April 21st were paid a $1.0568 dividend. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 dividend on an annualized basis and a yield of 2.63%. The ex-dividend date of this dividend was Monday, April 21st. Procter & Gamble's payout ratio is currently 67.14%.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines